Professional Documents
Culture Documents
Experimental Parasitology
journal homepage: www.elsevier.com/locate/yexpr
a r t i c l e
i n f o
Article history:
Received 17 August 2009
Received in revised form 15 January 2010
Accepted 18 January 2010
Available online 28 January 2010
Keywords:
Arginase (EC 3.5.3.1)
Metalloenzyme
Leishmania
Chemotherapy
a b s t r a c t
In Leishmania, arginase is responsible for the production of ornithine, a precursor of polyamines required
for proliferation of the parasite. In this work, the activation kinetics of immobilized arginase enzyme from
L. (L.) amazonensis were studied by varying the concentration of Mn2+ applied to the nickel column at
23 C. The intensity of the binding of the enzyme to the Ni2+ resin was directly proportional to the concentration of Mn2+. Conformational changes of the enzyme may occur when the enzyme interacts with
immobilized Ni2+, allowing the following to occur: (1) entrance of Mn2+ and formation of the metal
bridge; (2) stabilization and activation of the enzyme at 23 C; and (3) an increase in the afnity of the
enzyme to Ni2+ after the Mn2+ activation step. The conformational alterations can be summarized as follows: the interaction with the Ni2+ simulates thermal heating in the articial activation by opening a
channel for Mn2+ to enter.
2010 Elsevier Inc. All rights reserved.
1. Introduction
Arginase is a trimeric metalloenzyme containing a binuclear
manganese cluster in the active site of each subunit (Reczkowski
and Ash, 1992). In the mammalian liver, it is a cytosolic enzyme involved in the urea cycle, which converts arginine into ornithine
and urea (Krebs, 1942). In non-hepatic tissues, arginase is involved
in regulating the cellular concentration of L-arginine for nitric
oxide production (Forstermann et al., 1995) and ornithine for proline and polyamine biosynthesis (Wu and Morris, 1998; Chang
et al., 1998). In humans, an imbalance in the activity of arginase
in extra-hepatic tissue is related to a number of physiological disorders, such as hypertension and sexual impotence (Bagnost et al.,
2008; Cox et al., 1999). In the bacteria Helicobacter pylori, arginase
is responsible for the mechanism of escape from the immunologic
system (Gobert et al., 2001). In the parasitic protozoa Leishmania,
arginase plays a pivotal role in macrophage infection (Roberts
et al., 2004; Iniesta et al., 2001).
Establishing a metal bridge in the binuclear manganese center
is required for maximal activation of the native enzyme. Generally,
metal bridges are obtained in vitro by incubating the enzyme with
MnCl2 (50 mM) at 30, 40 or 55 C. Dissociation of one of the manganese atoms generates an enzyme with half of its catalytic activity (Hirsch-Kolb et al., 1971). In humans, H. pylori and Leishmania
arginase can be considered as a target for drug development, but
* Corresponding author.
E-mail address: edsilva@usp.br (E.R. Silva).
0014-4894/$ - see front matter 2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.exppara.2010.01.013
the required presence of 1 or 2 Mn2+ in each monomer must be taken into account. This requirement may be crucial for interpretation of the inhibitory results because the failure to prevent
arginase action could be associated with variation in its activation
state.
In an attempt to purify the enzyme through immobilized metal
afnity chromatography (IMAC), we discovered that the enzyme
could be activated without the need for heating in the presence
of Mn2+, which restores enzyme activity (da Silva et al., 2008). As
described in the molecular model that we proposed for parasite
arginase, it is possible that the major differences between parasite
arginase and rat hepatic arginase occur in the amino- and carboxyl-end groups, mainly at the S-shaped motif of the carboxylterminus. This work presents the kinetics of activation of the enzyme at low temperature, which point to particular features of
the Leishmania enzyme structure that allow its activation under
different conditions than those described for any other arginase
characterized so far.
2. Material and methods
2.1. Expression of recombinant arginase of L. (L.) amazonensis
Arginase was expressed without a His-tag on the BL21(DE3)pLysS strain of Escherichia coli containing a pRSET-Arg (plasmid
with the gene of arginase) and cultivated at 37 C in Super Optimal
Broth (SOB) medium containing 100 lg/mL ampicillin and 35 lg/
mL chloramphenicol to a culture optical density at 600 nm
153
154
Fig. 1. Proposed model for activation of arginase immobilized on Ni2+ resin by an inux of Mn2+ at low temperatures. S-shaped motif (red) in the carboxyl-terminus interacts
with nickel, disrupting the trimeric arrange and allowing the entrance of Mn2+ to the active site. After elution, active arginase is formed. (For interpretation of color mentioned
in this gure the reader is referred to the web version of the article.)
Acknowledgments
The authors thank Otvio H. Thiemann, Glaucius Oliva and
Richard Garrat for their incentives to develop this work. The research was supported by Conselho Nacional de Desenvolvimento
Cientco e Tecnolgico (CNPq) and Fundao de Amparo Pesquisa do Estado de So Paulo (FAPESP). E.R.S. received fellowships
from FAPESP.
References
the cell culture, a cytotoxicity of 20% was observed, while at 2.5 mM,
the toxicity reached 100%. The toxic dose where 50% of the cells are
affected is 1.3 mM Mn2+ (Parat et al., 1995). It is clear that both the
Bagnost, T., Berthelot, A., Bouhaddi, M., et al., 2008. Treatment with the arginase
inhibitor Nx-hydroxy-nor-L-arginine improves vascular function and lowers
blood pressure in adult spontaneously hypertensive rat. Journal of
Hypertension 26, 11101118.
Bewley, M.C., Lott, J.S., Baker, E.N., Patchett, M.L., 1996. The cloning,
expression and crystallisation of a thermostable arginase. FEBS Letters
386, 215218.
Bond, J.S., Failla, M.L., Unger, D.F., 1983. Elevated manganese concentration and
arginase activity in livers of streptozotocin-induced diabetic rats. The Journal of
Biological Chemistry 258, 80048009.
Chang, C.I., Liao, J.C., Kuo, L., 1998. Arginase modulates nitric oxide production in
activated macrophages. American Journal of PhysiologyHeart and Circulatory
Physiology 274, H342H348.
Colleluori, D.M., Morris Jr., S.M., Ash, D.E., 2001. Expression, purication, and
characterization of human type II arginase. Archives of Biochemistry and
Biophysics 389, 135143.
Cox, J.D., Kim, N.N., Traish, A.M., Christianson, D.W., 1999. Arginase-boronic acid
complex highlights a physiological role in erectile function. Nature Structural
Biology 6, 10431047.
da Silva, E.R., da Silva, M.F., Fischer, H., et al., 2008. Biochemical and biophysical
properties of a highly active recombinant arginase from Leishmania
155
Lavulo, L.T., Sossong Jr., T.M., Brigham-Burke, M.R., et al., 2001. Subunitsubunit
interactions in trimeric arginase. Generation of active monomers by mutation of
a single amino acid. The Journal of Biological Chemistry 276, 1424214248.
Parat, M.O., Richard, M.J., Leccia, M.T., et al., 1995. Does manganese protect cultured
human skin broblasts against oxidative injury by uva, dithranol and hydrogen
peroxide? Free Radical Research 23, 339351.
Reczkowski, R.S., Ash, D.E., 1992. EPR evidence for binuclear manganese(II) centers
in rat liver arginase. Journal of the American Chemical Society 114, 10992
10994.
Roberts, S.C., Tancer, M.J., Polinsky, M.R., et al., 2004. Arginase plays a pivotal role in
polyamine precursor metabolism in Leishmania. Characterization of gene
deletion mutants. The Journal of Biological Chemistry 279, 2366823678.
Scolnick, L.R., Kanyo, Z.F., Cavalli, R.C., et al., 1997. Altering the binuclear manganese
cluster of arginase diminishes thermostability and catalytic function.
Biochemistry 36, 1055810565.
Wu, G., Morris Jr., S.M., 1998. Arginine metabolism: nitric oxide and beyond.
Biochemical Journal 336, 117.